Cystic Fibrosis

Pathway Contributor: Jacqueline Lowdon

Credentials:
BSc, MSc, RD

Bio:
Jacqueline is a paediatric dietitian, with nearly 30 years of experience, working in the UK NHS. She specializes in paediatric cystic fibrosis.

Contributions:

• Do individuals with cystic fibrosis (CF) who supplement their diets with omega-3 fatty acid supplements (containing eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA)) have improved health outcomes compared with individuals with CF not consuming omega-3 fatty acid supplements?  

  Role: Reviewer

• What is the recommended nutrition management for the most common nutrition-related medical problems in cystic fibrosis (CF) (e.g. CF-related diabetes, low bone density)?  

  Role: Reviewer

• What are the recommendations for pancreatic enzyme replacement therapy (PERT) in individuals with cystic fibrosis?  

  Role: Reviewer

• What are the recommendations for nutrition screening, assessment and monitoring in children and adults with cystic fibrosis?  

  Role: Reviewer

• What are the recommendations for mineral supplementation in individuals with cystic fibrosis?  

  Role: Reviewer

• Do individuals with cystic fibrosis (CF) who supplement their diets with probiotics have improved health outcomes compared with individuals with CF not using probiotics?  

  Role: Reviewer

• Do infants, children and adults with cystic fibrosis (CF) have higher energy and macronutrient requirements compared to healthy infants, children and adults without CF?  

  Role: Reviewer

• What are the recommendations for fat-soluble vitamins in individuals with cystic fibrosis?  

  Role: Reviewer

View all Pathway Contributors